CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- 4 Planned sale Director sold 20,000 shares at $17.14 ($342,800)
- 4 Grant or award Director acquired 8,828 shares (grant or award)
- 4 Grant or award Director acquired 8,828 shares (grant or award)
- 4 Grant or award Director acquired 8,828 shares (grant or award)
- 4 Grant or award Director acquired 8,828 shares (grant or award)
- 4 Planned sale President and CEO sold 25,000 shares at $17.00 ($425,000)
- 4 Planned sale President and CEO sold 25,000 shares at $16.96 ($424,000)
- 4 Planned sale President and CEO sold 15,928 shares at an average $15.11 ($240,657)
- 4 Planned sale President and CEO sold 9,072 shares at an average $15.02 ($136,295)
- 4 Grant or award Senior VP, Finance and PAO acquired 21,600 shares (grant or award)
- 4 Grant or award Chief Revenue Officer acquired 28,421 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 30,695 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 30,695 shares (grant or award)
- 4 Grant or award President and CEO acquired 90,950 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chief Financial Officer acquired 1,000 shares (option exercise)
- 4 Open-market buy 10% owner bought 380,268 shares at $17.00 ($6,464,556)
- 3/A Insider 3/A
- 4 Grant or award Director acquired 6,618 shares (grant or award)
- 4 Open-market buy Director bought 237,234 shares at $17.00 ($4,032,978)
Page 6 of 7 · 135 filings